J Korean Ophthalmol Soc.  1996 Mar;37(3):452-458.

Effect of 1% Povidone-iodine for Ophthalmia Neonatorum Prophylaxis

Affiliations
  • 1Department of Ophthalmology, National Medical Center, Seoul, Korea.

Abstract

It has been reported that 2.5% povidone-iodine solution was an effective antimicrobial agent on the conjunctivae of newborns and caused less toxicity than silver nitrate eye drops. The effectiveness and the safety of 1% povidoneiodine solution, a lower concentration solution, were evaluated on ophthalmia neonatorum prophylaxis. A bacterial culture was taken from each conjunctiva of 70 neonates within 30 minutes after birth. A drop of each of the two agents, which were randomly chosen among 1% povidone-iodine solution, 2.5% povidone-iodine solution. and 1% silver nitrate eye drops, was placed on each conjunctiva. Conjunctival bacterial cultures were again taken two to four hours after birth. Before the first culture and at 24 hours after birth, the eyes were examined for toxic changes. To evaluate the effectiveness of the medications, the numbers of bacterial species and colonyforming units from each culture were compared. All three agents significantly reduced the numbers of species and colonyforming units(p<0.02). Two povidone-iodine solutions did not show significant ocular toxicity(p>0.7) but silver nitrate eye drop did(p<0.02). Therefore, it was found that 1% povidone-iodine solution as well as 2.5% povidone-iodine solution are effective antibacterial agents on the conjunctivae of newborns and cause less toxicity than silver nitrate eye drops.

Keyword

Ophthalmia neonatorum; Povidone-iodine; Silver nitrate

MeSH Terms

Anti-Bacterial Agents
Conjunctiva
Endophthalmitis*
Humans
Infant, Newborn
Ophthalmia Neonatorum*
Ophthalmic Solutions
Parturition
Povidone-Iodine*
Silver Nitrate
Anti-Bacterial Agents
Ophthalmic Solutions
Povidone-Iodine
Silver Nitrate
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr